Contact Us
Please complete the form, and a representative of Intelligent Bio Solutions will contact you shortly to assist with your enquiry.
Our Locations
New York
Intelligent Bio Solutions Inc.
Floor 5, 135 W 41st St,
New York, NY 10036,
United States
+1 646 790 5756
Office Hours
9am – 5pm Monday to Friday
Sydney
Intelligent Bio Solutions Inc.
Level 1, Suite 5,
28-40 Lord Street,
Botany, NSW, 2019
Australia
Office Hours
9am – 5pm Monday to Friday
Cambridge
14-17 Evolution Business Park,
Milton Road, Impington,
Cambridge, CB24 9NG,
United Kingdom
info@intelligentfingerprinting.com
+44 (0)1223 941941
Office Hours
9am – 5pm Monday to Friday
Media Contact
For media enquiries, please contact marketing@ibs.inc.
Investor Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
Find more information at investors.ibs.inc.
Connect With Us
Latest News
What Intelligent Bio Solutions Does and The Problem It Solves
Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a med tech company focused on delivering intelligent, rapid, non-invasive testing solutions. The company’s flagship product, the Intelligent Fingerprinting Drug Screening System, analyzes fingerprint sweat to detect drug use, supporting workplace safety across safety-critical industries, government and law-enforcement settings. INBS’ story is about more than an alternative approach…
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
NEW YORK, July 23, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has addressed all the cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This follows the Company’s recent completion of independent third-party penetration…
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
NEW YORK, July 21, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the completion of precision testing, a key component of the Company’s FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for detection…